{"id":"W2946496187","doi":"10.1111/hiv.12755","title":"Planning <scp>HIV</scp> therapy to prevent future comorbidities: patient years for tenofovir alafenamide","year":2019,"lang":"en","type":"review","venue":"HIV Medicine","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Tenofovir alafenamide; Medicine; Atazanavir; Ritonavir; Cobicistat; Lopinavir; Population; Internal medicine; Abacavir; Tolerability; Viral load; Adverse effect; Immunology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003472791,0.0002465759,0.0003188994,0.0002237846,0.00129546,0.001076054,0.0003212883,0.0008691318,0.02109152],"category_scores_gemma":[0.001124948,0.00009877742,0.0005291702,0.0001846976,0.0002115906,0.0009889266,0.0007476108,0.001537031,0.002996078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008449652,"about_ca_system_score_gemma":0.00221751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003039525,"about_ca_topic_score_gemma":0.007931279,"domain_scores_codex":[0.9998228,0.00005389936,0.00001570239,0.00001799252,0.00002921138,0.00006039022],"domain_scores_gemma":[0.9994938,0.00006013762,0.0000550848,0.00001049337,0.00006080289,0.0003196815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001019444,0.001193796,0.06094196,0.0005395895,0.00007040409,0.01886514,0.0009852831,0.001531118,0.003150117,0.00732576,0.3093487,0.5950286],"study_design_scores_gemma":[0.0004871879,0.002007032,0.08441615,0.003393099,0.000151502,0.03318675,0.003231573,0.003285484,0.003591029,0.02326661,0.8428299,0.0001535722],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.319496,0.04304993,0.01661931,0.196143,0.003874176,0.001827581,0.003300487,0.001261108,0.4144285],"genre_scores_gemma":[0.8279993,0.02095687,0.02632998,0.06280285,0.003001155,0.0008750498,0.002913822,0.0002285351,0.05489256],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02109152,"threshold_uncertainty_score":0.07055819,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07318189554706622,"score_gpt":0.3872819198777135,"score_spread":0.3141000243306473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}